mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NC_000913_3_bme_pgi | 526,792 | 0 | A | C | 27.9% | 90.2 / 37.4 | 70 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,796 | 0 | C | G | 27.9% | 111.3 / 47.1 | 68 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,800 | 0 | A | G | 27.7% | 99.8 / 33.3 | 66 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| Marginal new junction evidence (lowest skew 10 of 93 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913_3_bme_pgi | = 4385359 | 35 (0.880) | 6 (0.160) | 6/264 | 4.3 | 15.5% | intergenic (+17/‑35) | yjeM/yjeN | putative transporter/uncharacterized protein |
| ? | NC_000913_3_bme_pgi | = 4385364 | 33 (0.900) | intergenic (+22/‑30) | yjeM/yjeN | putative transporter/uncharacterized protein | |||||
| * | ? | NC_000913_3_bme_pgi | = 803472 | 47 (1.190) | 5 (0.130) | 5/268 | 4.8 | 10.6% | intergenic (+152/‑31) | ybhI/ybhJ | putative DASS family tricarboxylate or dicarboxylate transporter/aconitase family protein |
| ? | NC_000913_3_bme_pgi | = 803478 | 40 (1.080) | intergenic (+158/‑25) | ybhI/ybhJ | putative DASS family tricarboxylate or dicarboxylate transporter/aconitase family protein | |||||
| * | ? | NC_000913_3_bme_pgi | 781318 = | 51 (1.290) | 5 (0.130) | 5/270 | 4.8 | 9.0% | intergenic (+96/‑51) | lysY/lysZ | tRNA‑Lys/tRNA‑Lys |
| ? | NC_000913_3_bme_pgi | 781335 = | 53 (1.420) | intergenic (+113/‑34) | lysY/lysZ | tRNA‑Lys/tRNA‑Lys | |||||
| * | ? | NC_000913_3_bme_pgi | 164559 = | 42 (1.060) | 6 (0.160) | 5/268 | 4.8 | 14.1% | intergenic (+25/‑171) | hrpB/mrcB | putative ATP‑dependent helicase/fused glycosyl transferase and transpeptidase |
| ? | NC_000913_3_bme_pgi | = 3959482 | 34 (0.920) | intergenic (+37/+50) | ilvC/ppiC | ketol‑acid reductoisomerase, NAD(P)‑binding/peptidyl‑prolyl cis‑trans isomerase C (rotamase C) | |||||
| * | ? | NC_000913_3_bme_pgi | = 3946688 | 43 (1.080) | 6 (0.160) | 5/274 | 4.9 | 12.7% | intergenic (+81/‑12) | rrlC/rrfC | 23S ribosomal RNA of rrnC operon/5S ribosomal RNA of rrnC operon |
| ? | NC_000913_3_bme_pgi | = 4171601 | NA (NA) | intergenic (+57/‑36) | rrlB/rrfB | 23S ribosomal RNA of rrnB operon/5S ribosomal RNA of rrnB operon | |||||
| * | ? | NC_000913_3_bme_pgi | = 3390511 | 49 (1.240) | 6 (0.160) | 5/276 | 4.9 | 11.4% | intergenic (+62/+72) | aaeR/tldD | transcriptional regulator for aaeXAB operon/putative peptidase |
| ? | NC_000913_3_bme_pgi | = 3390524 | 46 (1.200) | intergenic (+75/+59) | aaeR/tldD | transcriptional regulator for aaeXAB operon/putative peptidase | |||||
| * | ? | NC_000913_3_bme_pgi | 2726200 = | NA (NA) | 6 (0.160) | 5/274 | 4.9 | NA | intergenic (‑12/+81) | rrfG/rrlG | 5S ribosomal RNA of rrnG operon/23S ribosomal RNA of rrnG operon |
| ? | NC_000913_3_bme_pgi | 2726224 = | NA (NA) | intergenic (‑36/+57) | rrfG/rrlG | 5S ribosomal RNA of rrnG operon/23S ribosomal RNA of rrnG operon | |||||
| * | ? | NC_000913_3_bme_pgi | = 2304902 | 20 (0.500) | 8 (0.260) +33 bp |
3/220 | 4.9 | 34.2% | noncoding (486/655 nt) | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences |
| ? | NC_000913_3_bme_pgi | = 2305065 | NA (NA) | noncoding (649/655 nt) | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 2304676 | 30 (0.760) | 8 (0.260) +33 bp |
3/220 | 4.9 | 25.7% | noncoding (260/655 nt) | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences |
| ? | NC_000913_3_bme_pgi | = 2305065 | NA (NA) | noncoding (649/655 nt) | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | |||||
| * | ? | NC_000913_3_bme_pgi | = 4051258 | 35 (0.880) | 4 (0.110) | 4/254 | 5.0 | 11.4% | noncoding (223/245 nt) | csrC | CsrC sRNA sequesters CsrA, a carbon flux regulator |
| ? | NC_000913_3_bme_pgi | = 4051262 | 31 (0.880) | noncoding (227/245 nt) | csrC | CsrC sRNA sequesters CsrA, a carbon flux regulator | |||||